ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2026
Prognostic value of the lactate-based modified cally score in postoperative gastric cancer patients admitted to the ICU.
Article in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGastric cancer is a major cause of cancer-related mortality, and reliable postoperative risk prediction is essential in critically ill patients. The C-reactive protein-albumin-lymphocyte (CALLY) index reflects inflammatory and nutritional status, while lactate indicates metabolic stress and tissue hypoperfusion. This study aimed to develop a lactate-based CALLY (CALLY-I) score and evaluate its prognostic value in postoperative gastric cancer patients admitted to the intensive care unit (ICU).
methodsThis retrospective study included 186 patients who underwent gastric cancer surgery and required postoperative ICU care between January 2022 and January 2025. Demographic characteristics, laboratory parameters, APACHE II and SAPS II scores, and derived indices (CALLY and CALLY-I) were analyzed. Predictors of 30- and 90-day mortality were assessed using Receiver Operating Characteristic (ROC) analyses, and significant variables were included in multivariate logistic regression.
resultsThe 30-day and 90-day mortality rates were 18.2% and 26.7%, respectively. Lactate demonstrated the strongest predictive ability for both 30-day (AUC = 0.865) and 90-day (AUC = 0.806) mortality. The CALLY-I score showed superior prognostic performance compared with the classical CALLY index and was an independent predictor of 30-day mortality (OR = 0.47, p = 0.032). APACHE II, albumin, and BUN were also independently associated with mortality, while the classical CALLY index did not show independent significance.
conclusionThe lactate-based CALLY-I score enhances prognostic accuracy by combining metabolic, inflammatory, and nutritional markers. CALLY-I may serve as a practical tool for postoperative risk stratification in gastric cancer patients requiring ICU monitoring. Prospective multicenter studies are needed for further validation.
Indexed as
Identifiers
41680587What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.